Cure Pharmaceutical operates in Pharmaceuticals, functioning as Manufacturer, based in United States, founded in 2017.
Cure Pharmaceutical is active in Pharmaceuticals, with 3 identified product associations including ELECTROLYTE ENERGY BOOST, CUREFILM ISONIAZID, and 3 ingredient links such as Fractionated Coconut Oil (Coconut Medium Chain Triglycerides) - Oil, Coconut Oil (Mct) - Oil, operating from United States.
Cure Pharmaceutical is linked to 3 ingredients: Fractionated Coconut Oil (Coconut Medium Chain Triglycerides) - Oil, Coconut Oil (Mct) - Oil, Carrageenan - Thickener. INCI names include Coconut Oil, Cocos Nucifera Oil. CAS references: 73398-61-5, 73398-61-5.
Cure Pharmaceutical has 3 product records: ELECTROLYTE ENERGY BOOST, CUREFILM ISONIAZID, CUREFILM BLUE, under brands: CUREPHARMACEUTICAL, within the Pharmaceuticals ecosystem.
Cure Pharmaceutical has 18 people records, including Cfo, Managing Partner, across C Suite, Partner levels.
This profile combines organization, product, ingredient, and narrative signals into a higher-fidelity company record.
CAS: 73398-61-5 · INCI: Coconut Oil
CAS: 73398-61-5 · INCI: Cocos Nucifera Oil
CAS: 01-07-9000 · INCI: Xanthan Gum
Brand: CUREPHARMACEUTICAL · Industry: Pharmaceuticals
Brand: CUREPHARMACEUTICAL · Industry: Pharmaceuticals
Brand: CUREPHARMACEUTICAL · Industry: Pharmaceuticals
Cure Pharmaceutical has 18 people records, including Cfo, Managing Partner, across C Suite, Partner levels.
Cure Pharmaceutical is related to companies such as Al Sedanah Jordan LLC, Avery Chemical (Nantong) Co., Ltd., Anhui Tiger Vitamin Development, identified through shared industry signals, ingredient overlap, and product ecosystem alignment.
Data-backed questions about Cure Pharmaceutical in Pharmaceuticals, United States.
Cure Pharmaceutical is linked to 3 product records: ELECTROLYTE ENERGY BOOST, CUREFILM ISONIAZID, CUREFILM BLUE.
Cure Pharmaceutical is associated with 3 ingredients: Fractionated Coconut Oil (Coconut Medium Chain Triglycerides) - Oil, Coconut Oil (Mct) - Oil, Carrageenan - Thickener. INCI names include: Coconut Oil, Cocos Nucifera Oil, Xanthan Gum.
Cure Pharmaceutical holds 1 certification: NSF. Types: certification.
Cure Pharmaceutical operates in Pharmaceuticals, with operations based in United States.
Cure Pharmaceutical was founded in 2017, making it 9 years active, headquartered in United States.
Cure Pharmaceutical is headquartered at 70 Queen's Road Central, Central, Hong Kong, Oxnard, California, 93030, United States, United States.
Disclaimer: All information contained in this database has been researched and compiled from many legitimate sources, believed to be accurate and reliable at the time of publishing. However, in view of the natural scope for human and/or mechanical error, either at source or during production, Dietary Business Intelligence (DBI) ( www.dbi360.com ) accepts no liability whatsoever for any loss or damage resulting from errors, inaccuracies or omissions affecting any part of the database. All information is provided without warranty, and DBI makes no representation of warranty of any kind as to the accuracy or completeness of any information hereto contained and strongly encourages that upon final material or product selection data points are validated with the supplier.
© Copyright 2026 Dietary Business Intelligence LLC. All Rights Reserved.
